$ORMP Cashflow Statement | Understand Stock

$ORMP

$4.08 -$0.05 (1.21%) Close

$ORMP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Aug 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Depreciation
Non-cash expense for acquired In-Process Research & Development (or IPR&D)
Non-cash expense for acquired In-Process Research & Development (“IPR&D”)
Gain from selling fixed assets
Exchange differences and interest on deposits and held to maturity bonds
Exchange differences and interest on deposits
Changes in fair value of investments
Stock-based compensation
Shares issued for services
Funds in respect of employee rights upon retirement
Accrued interest on short-term borrowings to maturity
Gain on amounts funded in respect of employee rights upon retirement
Change in accrued interest on short-term borrowings
Prepaid expenses and other current assets
Accounts payable, accrued expenses and related parties
Net changes in operating lease
Deferred revenues
Deferred income
Liability for employee rights upon retirement
Deferred tax liabilities
Other liabilities
Total net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Proceeds from selling fixed assets
Purchase of short-term deposits
Proceeds from sale of mutual funds
Purchase of held to maturity securities
Purchase of long-term deposits
Purchase of marketable securities
Investments at fair value
Proceeds from redemption of short-term deposits
Exercise of Closing Penny Warrants and Subsequent Penny Warrants
Long-term investments
Proceeds from loan to an equity method investee
Loan to investment in equity method
Equity method investee
Proceeds from long-term deposits
Proceeds from marketable securities
Proceeds from long-term investments and marketable securities
Proceeds from maturity of held to maturity securities
Funds in respect of employee rights upon retirement
Total net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of warrants and options
Repurchase and retirement of common stock
Loans received
Loans repaid
Tax withholdings related to stock-based compensation settlements
Transaction with non-controlling interests
Total net cash used in financing activities
EFFECT OF EXCHANGE RATE CHANGES ON CASH
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS AT END OF YEAR
(A) SUPPLEMENTARY DISCLOSURE ON CASH FLOWS:
Taxes paid
Interest paid
Interest received
(B) SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:
2024 Refinancing Tranche A
2024 Refinancing Tranche B
Excise tax for repurchase and retirement of common stock
IPR&D
Transaction with non-controlling interests
Additional paid in capital
Non-controlling interests
Recognition of operating lease right-of-use assets and liabilities
Waiver of loan granted to subsidiary
Derecognition of right-of-use asset
Derecognition of lease liability
Purchases of marketable securities not yet settled
Dividends declared but not yet paid in cash
Warrants received from Alpha Tau

Comments